- Home
- GRFS vs PFSI Comparison
GRFS vs PFSI Comparison
Compare GRFS & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRFS | PFSI |
|---|---|---|
| Founded | 1940 | 2008 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.9B |
| IPO Year | 2006 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GRFS | PFSI |
|---|---|---|
| Price | $8.92 | $132.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $10.30 | ★ $138.67 |
| AVG Volume (30 Days) | ★ 667.0K | 299.1K |
| Earning Date | 01-01-0001 | 10-21-2025 |
| Dividend Yield | ★ 1.60% | 0.91% |
| EPS Growth | N/A | ★ 191.00 |
| EPS | 0.64 | ★ 9.30 |
| Revenue | ★ $8,821,017,248.00 | $2,723,457,000.00 |
| Revenue This Year | $5.46 | $5.53 |
| Revenue Next Year | $5.60 | $29.51 |
| P/E Ratio | $17.34 | ★ $14.26 |
| Revenue Growth | 7.31 | ★ 21.25 |
| 52 Week Low | $6.19 | $85.74 |
| 52 Week High | $11.14 | $136.62 |
Technical Indicators
Market Signals| Indicator | GRFS | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 58.32 |
| Support Level | $7.64 | $131.64 |
| Resistance Level | $8.90 | $135.83 |
| Average True Range (ATR) | 0.27 | 3.17 |
| MACD | 0.07 | 0.38 |
| Stochastic Oscillator | 92.00 | 68.31 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.